At a glance
ClinicalIndex Comparison RecordN/ACompleted· 45 enrolled
Drug / intervention
TrueTeardevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of TrueTear Use on Anterior Corneal Surface Imaging Quality
In Brief
A clinical study evaluating TrueTear for Cataract and Myopia. Completed, enrolled 45 participants across 1 site.
Detailed Summary
This study will evaluate the utility of TrueTear™ to improve anterior corneal surface imaging quality before cataract surgery, refractive lens exchange, or laser refractive surgery.
Study Details
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartAug 2018
First PostedAug 2018
Primary CompletionJul 2019
TodayJul 2026
First PostedAug 20, 2018
Enrollment StartAug 13, 2018
Primary CompletionJul 8, 2019
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 7.9 years ago
Interventions
TrueTeardevice
Ues of TrueTear neurostimulator